Elam, Marshall B <br/><br/>
Association of Fenofibrate Therapy With Long-term Cardiovascular Risk in Statin-Treated Patients With Type 2 Diabetes.  [electronic resource] 

 -  JAMA cardiology  04 2017 
 - 370-380 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>2380-6591 
<br/><br/><label>Standard No.: </label>10.1001/jamacardio.2016.4828  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Biomarkers--blood<br/>Cardiovascular Diseases--blood<br/>Diabetes Mellitus, Type 2--blood<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Drug Therapy, Combination<br/>Dyslipidemias--blood<br/>Female<br/>Fenofibrate--therapeutic use<br/>Follow-Up Studies<br/>Humans<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--therapeutic use<br/>Hypolipidemic Agents--therapeutic use<br/>Lipids--blood<br/>Male<br/>Middle Aged<br/>Retrospective Studies<br/>Risk Factors<br/>Time Factors<br/>Treatment Outcome